HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sukrut Shah Selected Research

Platinum

1/2021Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.
4/2019KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sukrut Shah Research Topics

Disease

7Coronary Disease (Coronary Heart Disease)
02/2017 - 06/2004
6Neoplasms (Cancer)
01/2022 - 04/2019
3Hypercholesterolemia
08/2017 - 10/2002
2Stomach Neoplasms (Stomach Cancer)
01/2022 - 10/2020
2Adenocarcinoma
01/2022 - 01/2019
2Type 2 Diabetes Mellitus (MODY)
11/2017 - 03/2004
2Cardiovascular Diseases (Cardiovascular Disease)
05/2015 - 01/2015
1Microsatellite Instability
06/2021
1Esophageal Squamous Cell Carcinoma
01/2021
1Esophageal Neoplasms (Esophageal Cancer)
04/2019
1Stroke (Strokes)
11/2017
1Myocardial Infarction
11/2017
1Heart Failure
11/2017
1Hypertension (High Blood Pressure)
05/2011
1Body Weight (Weight, Body)
05/2011
1Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2011
1Overweight
05/2011
1Hyperlipidemias (Hyperlipidemia)
03/2004
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
04/2003

Drug/Important Bio-Agent (IBA)

7pembrolizumabIBA
01/2022 - 01/2019
7anacetrapibIBA
08/2017 - 10/2009
6HDL CholesterolIBA
08/2017 - 05/2011
6oxidized low density lipoproteinIBA
08/2017 - 05/2011
6LipidsIBA
08/2017 - 03/2004
6LDL CholesterolIBA
02/2017 - 03/2004
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2017 - 01/2015
4CholesterolIBA
08/2017 - 10/2002
4Cholesterol Ester Transfer ProteinsIBA
05/2015 - 01/2014
2PlatinumIBA
01/2021 - 04/2019
2Pharmaceutical PreparationsIBA
02/2017 - 01/2014
2Ezetimibe (Zetia)FDA Link
06/2004 - 10/2002
2Simvastatin (Zocor)FDA LinkGeneric
06/2004 - 03/2004
1Biomarkers (Surrogate Marker)IBA
06/2021
1B7-H1 AntigenIBA
01/2021
1Cisplatin (Platino)FDA LinkGeneric
01/2021
1Fluorouracil (Carac)FDA LinkGeneric
01/2021
1LigandsIBA
10/2020
1Dipeptidyl-Peptidase IV InhibitorsIBA
11/2017
12- (2,5- difluorophenyl)- 5- (2- (methylsulfonyl)- 2,6- dihydropyrrolo(3,4- c)pyrazol- 5(4H)- yl)tetrahydro- 2H- pyran- 3- amineIBA
11/2017
1omega-Chloroacetophenone (Mace)IBA
11/2017
1LDL Lipoproteins (beta Lipoproteins)IBA
08/2017
1Adenosine Triphosphate (ATP)IBA
02/2017
1HDL LipoproteinsIBA
01/2014
1Oxidoreductases (Dehydrogenase)IBA
05/2011
1Antihypertensive Agents (Antihypertensives)IBA
05/2011
1MK-0916IBA
05/2011
12,4-thiazolidinedione (thiazolidinedione)IBA
03/2004
1Finasteride (Propecia)FDA LinkGeneric
04/2003
1SterolsIBA
10/2002

Therapy/Procedure

9Therapeutics
01/2022 - 03/2004
7Drug Therapy (Chemotherapy)
01/2022 - 01/2019
1Immunotherapy
06/2021
1Withholding Treatment
01/2014